EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Fumarate reprograms the ubiquitinated proteome to confer ferroptosis resistance in clear cell renal cell carcinoma

Shiyin Fan, Jiaxi Li, Yi Gao, Yan Ma, Chuanxi Sun, Ziyin Tian, Yu Du, Jiatian Wang, Hongchen Li, Min Yu, Yanping Xu, Lei Lv

Cell Reports · 2026-11 · 45 (11) · 118282

DOI: 10.1016/j.celrep.2026.118282 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2026-11. Verfasst von Shiyin Fan und 11 weiteren Autor:innen. Beteiligte Einrichtung: MOE Key Laboratory of Metabolism and Molecular Medicine, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan Un…. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Hebei Province Science and Technology Support Program, Program for Professor of Special Appointment Eastern Scholar at Shanghai Institutions of Higher Learning, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clear cell renal cell carcinoma (ccRCC) is characterized by aberrant lipid accumulation and intrinsic ferroptosis sensitivity, yet how ccRCC escapes this vulnerability remains poorly understood. Here, we report that fumarate hydratase (FH) deficiency drives fumarate accumulation, which induces extensive remodeling of the ubiquitinated proteome and confers increased resistance to ferroptosis in ccRCC. Mechanistically, fumarate-mediated C706 succination of ubiquitin-like modifier-activating enzyme 1 (UBA1) significantly impairs its interaction with ubiquitin-conjugating enzyme E2 G2 (UBE2G2), concomitant with a global reduction of ubiquitination. Specifically, diminished ubiquitination increases the protein levels of activating transcription factor 4 (ATF4) and elevates solute carrier family 7 member 11 (SLC7A11) expression, thereby inhibiting ferroptosis. Importantly, a designed cell-penetrating peptide attenuates fumarate-induced UBA1 succination, suppresses ATF4-SLC7A11 axis, and enhances ferroptosis sensitivity of ccRCC. Collectively, these findings reveal that FH deficiency drives ubiquitinome dysregulation and suppresses ferroptosis, thereby linking ubiquitinated proteome reprogramming to tumor progression and suggesting potential therapeutic targets and strategies for treating ccRCC.

Schlagwörter

Stichwörter der Autor:innen

CP: cancerCP: metabolismccRCCferroptosisfumaratesuccinationubiquitinated proteome

Autor:innen und Institutionen

  • MOE Key Laboratory of Metabolism and Molecular Medicine, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai 200032, China; Department of Hepatic Surgery, Fudan…
  • MOE Key Laboratory of Metabolism and Molecular Medicine, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai 200032, China.
  • Tongji Hospital, Shanghai Key Laboratory of Signaling and Disease Research, Frontier Science Center for Stem Cell Research, School of Life Sciences and Technology, Tongji University, Shanghai 200120, China.
  • Tongji Hospital, Shanghai Key Laboratory of Signaling and Disease Research, Frontier Science Center for Stem Cell Research, School of Life Sciences and Technology, Tongji University, Shanghai 200120, China. Electronic a…
  • MOE Key Laboratory of Metabolism and Molecular Medicine, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai 200032, China; The Third Hospital of Mianyang, Sich…

Förderung

  • Hebei Province Science and Technology Support Program
  • Program for Professor of Special Appointment Eastern Scholar at Shanghai Institutions of Higher Learning
  • National Natural Science Foundation of China
  • Shanghai Rising-Star Program

Zitieren

APA

Fan, S., Li, J., Gao, Y., Ma, Y., Sun, C., Tian, Z., Du, Y., Wang, J., Li, H., Yu, M., Xu, Y., & Lv, L. (2026). Fumarate reprograms the ubiquitinated proteome to confer ferroptosis resistance in clear cell renal cell carcinoma. Cell Reports, 45(11), 118282. https://doi.org/10.1016/j.celrep.2026.118282

Vancouver

Fan S, Li J, Gao Y, Ma Y, Sun C, Tian Z, et al. Fumarate reprograms the ubiquitinated proteome to confer ferroptosis resistance in clear cell renal cell carcinoma. Cell Reports. 2026;45(11):118282. doi:10.1016/j.celrep.2026.118282

BibTeX
@article{Fan2026,
  author = {Fan, Shiyin and Li, Jiaxi and Gao, Yi and Ma, Yan and Sun, Chuanxi and Tian, Ziyin and Du, Yu and Wang, Jiatian and Li, Hongchen and Yu, Min and Xu, Yanping and Lv, Lei},
  title = {Fumarate reprograms the ubiquitinated proteome to confer ferroptosis resistance in clear cell renal cell carcinoma},
  journal = {Cell Reports},
  year = {2026},
  volume = {45},
  number = {11},
  pages = {118282},
  doi = {10.1016/j.celrep.2026.118282}
}
Kostenlos starten →